valproate - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Valproate-containing medicines - new measures regarding the potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the 3 months prior to conception

Key facts

• Active substance:
  valproate
• Therapeutic area (MeSH):
  • Epilepsy
  • Bipolar Disorder
  • Migraine Disorders
• Procedure number:
  EMEA/H/N/PSR/J/0043
• Regulatory outcome:
  Variation
• DHPC type:
  Post-authorisation measure
• Human ATC codes:
  N03AG01
• Dissemination date:
  19/02/2024